Learn More
Selleck Chemical LLC NX-1607 E1957-100MG

Supplier: Selleck Chemical LLC E1957100MG
NX-1607 (Cbl-b-IN-3) is an oral inhibitor of Casitas B-lineage lymphoma proto-oncogene B (CBL-B) which is an E3 ubiquitin ligase and a key regulator of T NK and dendritic cell activation and suppresses their anti-tumor functions NX-1607 enhances antigen recall reduces T cell exhaustion and increases cytokine production in response to T cell receptor stimulation thereby counteracting suppressive signals from the tumor microenvironment
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.